Changes in Cardiff’s C-suite amid late-stage push for cancer candidate

Among management moves this week, Cardiff Oncology Inc. (NASDAQ:CRDF) said it would replace CEO Mark Erlander and CFO James Levine as it prepares to move PLK1 inhibitor onvansertib into registrational testing for colorectal cancer. Board member Mani Mohindru will step into the CEO role on an interim basis, while SVP of Finance Brigitte Lindsay will become chief accounting officer...